Clinical Trial Update: Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-1816 in Healthy Subjects [Phase 1]

View source ↗

Summary

This is a Phase 1 single ascending dose and multiple-dose study of SHR-1816 in healthy subjects to assess safety, tolerability, pharmacokinetics and pharmacodyn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• SHR-1816

Snippet

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd | Conditions: Diabetes | Phase 1 | Status: TERMINATED